Needle-Free Biologics Delivery

Anodyne Nanotech is a Boston-based Tufts University spinout developing HeroPatch, a dissolving microneedle patch platform for needle-free delivery of biologics. The company’s lead program targets transdermal delivery of GLP-1 drugs for obesity, with Phase 1 clinical trials planned. Backed by early-stage investors and supported by an exclusive license from Tufts University.